Back to Rankings

PULM

PulmatrixD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PULM vs peer average
55/100
PULM vs. peer average (D vs. D)
Grade spread
B 1 · C 1 · D 1 · F 6
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

ENVB is the first available peer comparator.

Micro-cap biotech with thin coverage and high execution risk; helpful as a comparator for sentiment fragility when strategic or funding updates outweigh operating progress.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerENVBEnveric Biosciences
PULM
Pulmatrix
ENVB
Enveric Biosciences
Grade
D
B
Momentum
66
97
Value
42
41
Sentiment
36
31
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs ENVB

PULM / ENVB
Grade Position
In line
PULM vs. peer average (D vs. D)
55/100
Momentum
66
ENVB
Value
42
PULM
Sentiment
36
PULM

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PULM
1
ENVB
ENVB
B
80/100
-2
2
MBIO
MBIO
D
40/100
Even
3
RVPH
RVPH
-
-
-
4
SBFM
Sunshine Biopharma Inc Common
C
60/100
-1
5
RNAZ
TransCode Therapeutics Inc Common
F
20/100
+1
ENVB is the first peer returned for this comparison set.